Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients-Reference-Cited by-同舟云学术

Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients

Published:2012-05-07 Issue:1 Volume:53 Page:115-122
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Lefrère François,Bastit-Barrau Dominique,Hequet Olivier,Bourin Philippe,Mathieu-Nafissi Suzanne,Bohbot Alain,Tilly Hervé,Salles Gilles,Fermé Christophe,Lapierre Valérie,Fornecker Luc,Micléa Jean-Michel,Isebaert Loic,Bologna Serge,Fitoussi Olivier,Mounier Nicolas,Haioun Corinne

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1537-2995.2012.03683.x/fullpdf

Reference34 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

2. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol-a Groupe d'Etude des Lymphomes de l'Adulte study;Haioun;J Clin Oncol,2000

3. Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma;Pettengell;J Clin Oncol,1996

4. Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support;Milpied;N Engl J Med,2004

5. Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies;André;Transfusion,2003

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mobilization and Hematopoietic Stem Cell Collection in Poor Mobilizing Patients with Lymphoma: Final Results of the German OPTIMOB Study;Transfusion Medicine and Hemotherapy;2023

2. A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections;Critical Reviews in Oncology/Hematology;2016-01

3. Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma;Chinese Journal of Cancer;2015-09-14

4. Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective;European Journal of Haematology;2014-05-26